Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Morari

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 9, 2007
The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathwayMatteo Marti, Claudio Trapella, Riccardo Viaro, et al.
Biochemical Society Transactions|February 28, 2022
Modeling Parkinson's disease in LRRK2 mice: focus on synaptic dysfunction and the autophagy-lysosomal pathwayFederica Albanese, Chiara Domenicale, Mattia Volta, et al.
Neurological Research|May 4, 2011
NR2B subunit blockade does not affect motor symptoms induced by 3-nitropropionic acidMartina Fantin, Michele Morari, François Tison, et al.
Journal of Neurochemistry|December 20, 2008
Stimulation of delta opioid receptors located in substantia nigra reticulata but not globus pallidus or striatum restores motor activity in 6-hydroxydopamine lesioned rats: new insights into the role of delta receptors in parkinsonismOmar S Mabrouk, Mattia Volta, Matteo Marti, et al.
Handbook of Experimental Pharmacology|January 29, 2019
NOP Receptor Ligands and Parkinson's DiseaseDaniela Mercatelli, Clarissa Anna Pisanò, Salvatore Novello, et al.
Neuropharmacology|September 8, 2009
The selective D(3) receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect L-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned ratsFlora Mela, Mark J Millan, Mauricette Brocco, et al.
Journal of Neurochemistry|November 8, 2007
NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathwaysMartina Fantin, Matteo Marti, Yves P Auberson, et al.
Experimental Neurology|January 11, 2011
Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activityMattia Volta, Riccardo Viaro, Claudio Trapella, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 25, 2015
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activityGiovanna Paolone, Alberto Brugnoli, Ludovico Arcuri, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2008
Nociceptin/orphanin FQ modulates motor behavior and primary motor cortex output through receptors located in substantia nigra reticulataMatteo Marti, Riccardo Viaro, Remo Guerrini, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 9, 2007
The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathwayMatteo Marti, Claudio Trapella, Riccardo Viaro, et al.
Biochemical Society Transactions|February 28, 2022
Modeling Parkinson's disease in LRRK2 mice: focus on synaptic dysfunction and the autophagy-lysosomal pathwayFederica Albanese, Chiara Domenicale, Mattia Volta, et al.
Neurological Research|May 4, 2011
NR2B subunit blockade does not affect motor symptoms induced by 3-nitropropionic acidMartina Fantin, Michele Morari, François Tison, et al.
Journal of Neurochemistry|December 20, 2008
Stimulation of delta opioid receptors located in substantia nigra reticulata but not globus pallidus or striatum restores motor activity in 6-hydroxydopamine lesioned rats: new insights into the role of delta receptors in parkinsonismOmar S Mabrouk, Mattia Volta, Matteo Marti, et al.
Handbook of Experimental Pharmacology|January 29, 2019
NOP Receptor Ligands and Parkinson's DiseaseDaniela Mercatelli, Clarissa Anna Pisanò, Salvatore Novello, et al.
Neuropharmacology|September 8, 2009
The selective D(3) receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect L-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned ratsFlora Mela, Mark J Millan, Mauricette Brocco, et al.
Journal of Neurochemistry|November 8, 2007
NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathwaysMartina Fantin, Matteo Marti, Yves P Auberson, et al.
Experimental Neurology|January 11, 2011
Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activityMattia Volta, Riccardo Viaro, Claudio Trapella, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 25, 2015
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activityGiovanna Paolone, Alberto Brugnoli, Ludovico Arcuri, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2008
Nociceptin/orphanin FQ modulates motor behavior and primary motor cortex output through receptors located in substantia nigra reticulataMatteo Marti, Riccardo Viaro, Remo Guerrini, et al.
Pageof 10